An 85-year-old male who had undergone Roux-en-Y reconstruction following distal gastrectomy for gastric cancer was admitted to our hospital with jaundice. Computed tomography showed lymph node recurrence causing bile duct obstruction \[[Figure 1a](#F1){ref-type="fig"}\]. At first, we attempted transpapillary biliary stenting using a single-balloon enteroscope. However, this failed because cannulation to the bile duct was difficult. Therefore, we conducted EUS-guided antegrade stenting (EUS-AGS) \[Figure [1b](#F1){ref-type="fig"}, [c](#F1){ref-type="fig"} and [Video 1](#SD1){ref-type="supplementary-material"}\]. EUS showed intrahepatic bile duct dilation. First, the B2 branch was punctured using a 19-gauge needle. A 0.025-inch guidewire (VisiGlide 2; Olympus Medical Systems, Tokyo, Japan) was inserted into the biliary tract, followed by a double-lumen cannula (Uneven double-lumen cannula; Piolax Medical Devices, Kanagawa, Japan). An additional 0.035-inch guidewire (Wrangler Major; Piolax Medical Devices) was also inserted to stabilize the axis. After advancing the guidewire into the intestine across the stricture, the biliary obstruction site was evaluated in detail. Next, a braided uncovered metal stent with a slim delivery system (Niti-S large cell SR slim delivery; Taewoong Medical, Seoul, Korea; delivery system: 6-Fr diameter, 196 cm length) was smoothly inserted without additional dilation of the fistula. The stent was placed from the intestine to the upper common bile duct. Finally, a plastic stent (TYPE-IT stent; Gadelius Medical Co., Ltd., Tokyo, Japan; total length: 20 cm, effective length 15 cm) was also placed from the intrahepatic duct to the residual stomach. No procedure-related complications occurred and the jaundice resolved.

![(a) Computed tomography showing a lymph node recurrence of gastric cancer causing bile duct obstruction (arrow). (b) EUS-guided cholangiography showing a stricture of the distal bile duct. (c) EUS-guided antegrade stenting combined with hepaticogastrostomy was successfully conducted](EUS-9-141-g001){#F1}

The structures of metal stents are broadly divided into laser cut type and braided type. Until recently, only laser cut stents represented by Zilver stent (Cook, Bloomington, IN, USA) had a slim delivery system of 6-Fr or less. However, they have the disadvantage of weaker radial force causing weaker expandability.\[[@ref1][@ref2]\] Currently, a braided metal stent with a 6-Fr novel slim delivery system (Niti-S large cell SR slim delivery; Taewoong Medical) has been developed \[Figure [2a](#F2){ref-type="fig"} and [b](#F2){ref-type="fig"}\]. When conducting EUS-guided biliary drainage, the risk of bile leakage should be minimized by using slim devices.\[[@ref3][@ref4]\] We believe that the developed braided metal stent is suitable for EUS-AGS because of the advantages of stronger expandability and the 6-Fr slim delivery system.

![(a) A braided uncovered metal stent (Niti-S large cell SR slim delivery; Taewoong Medical, Seoul, Korea). (b) Comparison of delivery systems. Right side: A 6-Fr novel slim delivery system (Niti-S large cell SR slim delivery; Taewoong Medical), left side: An 8-Fr normal delivery system (Niti-S large cell D-type stent; Taewoong Medical)](EUS-9-141-g002){#F2}
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